|
INN ▲
|
ATC Code ▼
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
FLUDARABINE |
L01BB05 |
DE
|
Currently not available
|
|
DE/H/0801/001/II/004 |
09-11-2009 |
VALID
|
|
PEMETREXED |
L01BA04 |
DE
|
POM
|
14-05-2018 |
DE/H/4233/002/ |
10-12-2015 |
VALID
|
|
METHOTREXATE |
L01BA01 |
DE
|
POM
|
23-01-2019 |
DE/H/4083/001/ |
02-04-2015 |
VALID
|
|
TEMOZOLOMIDE |
L01AX03 |
DE
|
POM
|
14-05-2018 |
|
|
VALID
|
|
BUSULFAN |
L01AB01 |
DE
|
Currently not available
|
|
DE/H/4104/001/ |
07-12-2015 |
VALID
|
|
MELPHALAN FLUFENAMIDE |
L01AA10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005681 |
17-08-2022 |
VALID
|
|
BENDAMUSTINE |
L01AA09 |
DE
|
POM
|
09-04-2018 |
DE/H/1250/001/ |
29-06-2014 |
VALID
|
|
CHIKUNGUNYA VACCINES |
J07BX07 |
DE
|
Not authorised
|
02-05-2025 |
EMEA/H/C/005797 |
28-06-2024 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
SINGLE-STRANDED 5' CAPPED MRNA ENCODING RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN F STABILIZED |
J07BX05 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006278 |
22-08-2024 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
COVID-19 VACCINES |
J07BX03 |
DE
|
POM
|
18-01-2021 |
EMEA/H/C/005735 |
21-12-2020 |
VALID
|
|
EBOLA VACCINES |
J07BX02 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004554 |
11-11-2019 |
VALID
|
|
INFLUENZA VACCINE (LIVE ATTENUATED, NASAL) |
J07BB03 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006514 |
03-06-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) |
J07BB02 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/006538 |
15-11-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN |
J07BB02 |
DE
|
POM
|
21-10-2019 |
EMEA/H/C/004814 |
12-12-2018 |
VALID
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005451 |
14-02-2022 |
VALID
|
|
SIPAVIBART |
J06BD09 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/006291 |
20-01-2025 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
SOTROVIMAB |
J06BD05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005676 |
17-12-2021 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
OBILTOXAXIMAB |
J06BC04 |
DE
|
Not authorised
|
18-01-2021 |
|
|
VALID
|
|
LENACAPAVIR |
J05AX31 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
DE
|
POM
|
02-06-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
BULEVIRTIDE |
J05AX28 |
DE
|
POM
|
22-12-2020 |
EMEA/H/C/004854 |
31-07-2020 |
VALID
|
|
TECOVIRIMAT |
J05AX24 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005248 |
06-01-2022 |
VALID
|
|
LETERMOVIR |
J05AX18 |
DE
|
POM
|
26-04-2022 |
|
|
VALID
|
|
MARIBAVIR |
J05AX10 |
DE
|
I
|
14-11-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
MARAVIROC |
J05AX09 |
DE
|
I
|
|
None |
|
VALID
|
|
LYSOZYME |
J05AX02 |
DE
|
Not subject to prescription
|
|
None |
|
VALID
|
|
LAMIVUDINE AND DOLUTEGRAVIR |
J05AR25 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004909 |
30-06-2019 |
VALID
|
|
LAMIVUDINE, TENOFOVIR DISOPROXIL AND DORAVIRINE |
J05AR24 |
DE
|
POM
|
21-10-2019 |
EMEA/H/C/004746 |
22-11-2018 |
VALID
|
|
EMTRICITABINE, TENOFOVIR ALAFENAMIDE, ELVITEGRAVIR AND COBICISTAT |
J05AR18 |
DE
|
POM
|
|
|
|
VALID
|
|
ATAZANAVIR AND COBICISTAT |
J05AR15 |
DE
|
POM
|
|
|
|
VALID
|
|
DARUNAVIR AND COBICISTAT |
J05AR14 |
DE
|
POM
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR DISOPROXIL, ELVITEGRAVIR AND COBICISTAT |
J05AR09 |
DE
|
POM
|
11-10-2017 |
|
|
VALID
|
|
TENOFOVIR DISOPROXIL AND EMTRICITABINE |
J05AR03 |
DE
|
Not authorised
|
21-10-2019 |
|
|
VALID
|
|
LAMIVUDINE AND ABACAVIR |
J05AR02 |
DE
|
I
|
|
None |
|
VALID
|
|
SOFOSBUVIR AND VELPATASVIR |
J05AP55 |
DE
|
POM
|
|
|
|
VALID
|
|
ELBASVIR AND GRAZOPREVIR |
J05AP54 |
DE
|
POM
|
|
|
|
VALID
|
|
OMBITASVIR, PARITAPREVIR AND RITONAVIR |
J05AP53 |
DE
|
POM
|
|
|
|
VALID
|
|
SOFOSBUVIR AND LEDIPASVIR |
J05AP51 |
DE
|
POM
|
|
|
|
VALID
|
|
DASABUVIR |
J05AP09 |
DE
|
POM
|
25-01-2018 |
|
|
VALID
|
|
SOFOSBUVIR |
J05AP08 |
DE
|
POM
|
|
|
|
VALID
|
|
DACLATASVIR |
J05AP07 |
DE
|
POM
|
|
EMEA/H/C/003768 |
|
VALID
|
|
SIMEPREVIR |
J05AP05 |
DE
|
POM
|
|
|
|
VALID
|
|
BOCEPREVIR |
J05AP03 |
DE
|
Not authorised
|
01-06-2021 |
|
|
VALID
|
